We will be participating in several events over the coming weeks. Join us at a conference near you to experience CARL firsthand and speak with our team in person.

Our reperfusion sets are fully CE-certified and approved for 30 days of continuous use.

CARL has been featured in a CNN news report in Brazil for the very first time. This marks an important step as CARL continues its regulatory pathway.

Two CARL Controllers were donated to the Kyiv Heart Institute and have now been used for the first time – with great success.

CARL. has won the prestigious Prix Galien USA 2025 Award, widely regarded as the “Nobel Prize of biopharmaceutical research”.

Together with Dr. Tom Lines, we are broadening our research and development capabilities.

For the first time at St. Antonius Hospital in Kleve, the CARL ONE Controller was used on a critically ill patient with acute cardiac arrest.

We are excited to share the new video that illustrates our vision for the chain of survival in out-of-hospital cardiac arrest (OHCA).